Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2

Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma

(2016) Amir Mehdizadeh et al.   MOLECULAR BIOLOGY REPORTS

The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231)

(2016) Peyman Eivazy et al.   Artificial Cells Nanomedicine and Biotechnology

ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins

(2015) Lixia Bai et al.   MEDICAL ONCOLOGY

Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines

(2015) Simone Gusenbauer et al.   Molecular Cancer

MEK1/2 inhibitors in the treatment of gynecologic malignancies

(2014) Caela R. Miller et al.   GYNECOLOGIC ONCOLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age

(2014) Koji Miyahara   WORLD JOURNAL OF GASTROENTEROLOGY

Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

(2013) I. Canadas et al.   CLINICAL CANCER RESEARCH

Nuclear translocation of pro-amphiregulin induces chemoresistance in gastric cancer

(2012) Michihiro Yoshida et al.   CANCER SCIENCE

ERK1/2 MAP kinases: Structure, function, and regulation

(2012) Robert Roskoski   PHARMACOLOGICAL RESEARCH

Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines

(2011) KAZUYA UCHIBORI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

ERK2 but Not ERK1 Induces Epithelial-to-Mesenchymal Transformation via DEF Motif-Dependent Signaling Events

(2010) Sejeong Shin et al.   MOLECULAR CELL

Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy

(2009) Zhe Zhang et al.   BMC Medicine

Targeting the RAF–MEK–ERK pathway in cancer therapy

(2009) Clara Montagut et al.   CANCER LETTERS

Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2

(2009) Christophe Frémin et al.   HEPATOLOGY

Resistance to Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitors Correlates with Up-Regulation of the MEK/Extracellular Signal-Regulated Kinase Pathway in Hepatocellular Carcinoma Cells

(2009) M. T. Yip-Schneider et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS